Abstract:WHAT IS KNOWN AND OBJECTIVE: Like many countries in the world, China is also facing growing drug expenditures year by year. In particular, the rising cost of prescription drugs has been one of the critical factors leading to the serious burden on health insurance programs. The high cost of prescription drugs not only threatens the health budget but also limits the nation's investment in other public sectors. China implemented the National Centralized Drug Procurement (NCDP) policy, also known as the "4 + 7" policy, in tertiary hospitals in various provinces and cities across the country on 18 December 2019, aiming to lessen personal and national health insurance burdens by reducing drug procurement prices. The aim of this study is to explore the impact of the implementation of the NCDP policy on the drug expenditures of patients treated in outpatient and emergency departments and on national health insurance expenditures.METHODS: This study adopts interrupted time series (ITS) to evaluate the impact of China's implementation of the NCDP policy on the drug expenditures of patients treated in outpatient and emergency departments in a tertiary hospital. The NCDP policy was officially implemented on 18 December 2019. A segmented regression model is utilized to analyse the average monthly drug expenditures of patients treated in outpatient and emergency departments from January 2018 to June 2021, including the average monthly per-visit drug expenditures of all patients and the average monthly per-visit drug expenditures of patients who paid for drugs with health insurance and those who did not use health insurance.RESULTS: After the implementation of the NCDP policy, the overall average monthly per-visit drug expenditures of patients treated in outpatient and emergency departments were immediately reduced by 233.954 CNY (p < 0.01). Compared with the continued downward trend for drug expenditures before the implementation of the NCDP policy, the long-term trend after policy implementation was not obvious (p = 0.051973>0.05). Similarly, the average monthly per-visit drug expenditures of patients treated in outpatient and emergency departments who use health insurance to procure drugs also immediately decreased by 505.287 CNY (p < 0.01), but the long-term trends before (p = 0.469>0.05) and after policy implementation (p = 0.51>0.05) did not exhibit obvious change. For the average monthly per-visit drug expenditures of patients treated in outpatient and emergency departments who did not use health insurance, the implementation of the NCDP policy did not produce an immediate reduction in drug expenditures (p = 0.3603>0.05). Although the average monthly per-visit drug expenditures decreased by 9.078 CNY (p < 0.01) before policy implementation, this trend ended after the policy was implemented (p = 0.0735>0.05), and no other changes were triggered.WHAT IS NEW AND CONCLUSION: This study reviews the data for a period of time before and after the implementation of the NCDP policy. The policy is shown to significantly decrease the average monthly per-visit drug expenditures of patients treated in outpatient and emergency departments.

The Impact of the National Essential Medicines Policy on Rational Drug Use in Primary Care Institutions in Jiangsu Province of China.

The Impact of China's National Essential Medicine System on Improving Rational Drug Use in Primary Health Care Facilities: an Empirical Study in Four Provinces.

The Effect of Essential Medicines Programme on Rational Use of Medicines in China

Retrospective Survey of the Efficacy of Mandatory Implementation of the Essential Medicine Policy in the Primary Healthcare Setting in China: Failure to Promote the Rational Use of Antibiotics in Clinics.

Impacts of the Essential Medicine System on Rational Drug Use in Community Health Service Centers

Effectiveness of Continuous Improvement by a Clinical Pharmacist-Led Guidance Team on the Prophylactic Antibiotics Usage Rationality in Intervention Procedure at a Chinese Tertiary Teaching Hospital

Short- and long-term impacts of the National Essential Medicines Policy on drug availability, price, and usage in a deprived rural county in southwestern China: an interrupted time series analysis across 8 years

Impact of Essential Medicine System on Rational Drug Use in Basic Medical Units in Mid-Western China

Effects of the Implementation of National Essential Drug System on Rational Use of Drugs in Community Health Service Center from Shanghai City

The Impact of China's National Essential Medicine Policy and Its Implications for Urban Outpatients: A Multivariate Difference-in-Differences Study.

Does Economic Incentive Matter for Rational Use of Medicine? China’s Experience from the Essential Medicines Program

Trends analysis for drug utilization in county public hospitals: a sample study of the pilot area of health care reform in China

Evaluation of the Medication Rationality of National Essential Medicine System in Township Hospitals Imple-menting HealthⅪProject in Heilongjiang Province

An Analysis on Rational Use and Affordability of Medicine after the Implementation of National Essential Medicines Policy and Zero Mark-up Policy in Hangzhou, China

Effects of essential medicine policy on rationality of outpatient medication in township health centers of Gansu province

Analysis of rational prescription of medicines by village clinics: a repeated cross-sectional study of a province in eastern China

Impact of ‘Chief-Pharmacist System’ on drug expenditures and rational drug use

Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level‐A hospital in China: A single centre, interrupted time series

Analysis on Effects of Essential Medicine Policy of Gansu Province to Village/Town Health Centers' Out-patient Medication Rationality

Evaluation, in Three Provinces, of the Introduction and Impact of China'S National Essential Medicines Scheme

Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China